Maarten De Vos

Prof. Maarten De Vos

Department of Electrical Engineering and Department of Development and regeneration, KU Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2020 in BMJ
Verified
Journal Article
Open access
PDF file
LWLaure Wynants
Laure Wynants
BCBen Van Calster
Ben Van Calster
MBMarc Bonten
Marc Bonten
GCGary S Collins
Gary S Collins
TDThomas P. Debray
Thomas P. Debray
MSMaarten van Smeden
Maarten van Smeden
Objective: To review and appraise the validity and usefulness of published and preprint reports of prediction models for prognosis of patients with covid-19, and for detecting people in the general population at increased risk of covid-19 infection or being admitted to hospital or dying with the disease. Design: Living systematic review and critical appraisal by the covid-PRECISE (Precise Risk Estimation to optimise covid-19 Care for Infected or Suspected patients in diverse sEttings) group. Data sources: PubMed and Embase through Ovid, up to 17 February 2021, supplemented with arXiv, medRxiv, and bioRxiv up to 5 May 2020. Study selection: Studies that developed or validated a multivariable covid-19 related prediction model. Data extraction: At least two authors independently extracted data using the CHARMS (critical appraisal and data extraction for systematic reviews of prediction modelling studies) checklist; risk of bias was assessed using PROBAST (prediction model risk of bias assessment tool). Results: 126 978 titles were screened, and 412 studies describing 731 new prediction models or validations were included. Of these 731, 125 were diagnostic models (including 75 based on medical imaging) and the remaining 606 were prognostic models for either identifying those at risk of covid-19 in the general population (13 models) or predicting diverse outcomes in those individuals with confirmed covid-19 (593 models). Owing to the widespread availability of diagnostic testing capacity after the summer of 2020, this living review has now focused on the prognostic models. Of these, 29 had low risk of bias, 32 had unclear risk of bias, and 545 had high risk of bias. The most common causes for high risk of bias were inadequate sample sizes (n=408, 67%) and inappropriate or incomplete evaluation of model performance (n=338, 56%). 381 models were newly developed, and 225 were external validations of existing models. The reported C indexes varied between 0.77 and 0.93 in development studies with low risk of bias, and between 0.56 and 0.78 in external validations with low risk of bias. The Qcovid models, the PRIEST score, Carr’s model, the ISARIC4C Deterioration model, and the Xie model showed adequate predictive performance in studies at low risk of bias. Details on all reviewed models are publicly available at https://www.covprecise.org/ . Conclusion: Prediction models for covid-19 entered the academic literature to support medical decision making at unprecedented speed and in large numbers. Most published prediction model studies were poorly reported and at high risk of bias such that their reported predictive performances are probably optimistic. Models with low risk of bias should be validated before clinical implementation, preferably through collaborative efforts to also allow an investigation of the heterogeneity in their performance across various populations and settings. Methodological guidance, as provided in this paper, should be followed because unreliable predictions could cause more harm than benefit in guiding clinical decisions. Finally, prediction modellers should adhere to the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) reporting guideline. Systematic review registration: Protocol https://osf.io/ehc47/ , registration https://osf.io/wy245 . Readers’ note: This article is the final version of a living systematic review that has been updated over the past two years to reflect emerging evidence. This version is update 4 of the original article published on 7 April 2020 ( BMJ 2020;369:m1328). Previous updates can be found as data supplements ( https://www.bmj.com/content/369/bmj.m1328/related#datasupp ). When citing this paper please consider adding the update number and date of access for clarity.

31 August 2020 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
HPHuy Phan
Huy Phan
OCOliver Chén
Oliver Chén
PKPhilipp Koch
Philipp Koch
ZLZongqing Lu
Zongqing Lu
Ian McLoughlinIan McLoughlin
Ian McLoughlin
Maarten De VosMaarten De Vos
Maarten De Vos
Background: Despite recent significant progress in the development of automatic sleep staging methods, building a good model still remains a big challenge for sleep studies with a small cohort due to the data-variability and data-inefficiency issues. This work presents a deep transfer learning approach to overcome these issues and enable transferring knowledge from a large dataset to a small cohort for automatic sleep staging. Methods: We start from a generic end-to-end deep learning framework for sequence-to-sequence sleep staging and derive two networks as the means for transfer learning. The networks are first trained in the source domain (i.e. the large database). The pretrained networks are then finetuned in the target domain (i.e. the small cohort) to complete knowledge transfer. We employ the Montreal Archive of Sleep Studies (MASS) database consisting of 200 subjects as the source domain and study deep transfer learning on three different target domains: the Sleep Cassette subset and the Sleep Telemetry subset of the Sleep-EDF Expanded database, and the Surrey-cEEGrid database. The target domains are purposely adopted to cover different degrees of data mismatch to the source domains. Results: Our experimental results show significant performance improvement on automatic sleep staging on the target domains achieved with the proposed deep transfer learning approach. Conclusions: These results suggest the efficacy of the proposed approach in addressing the above-mentioned data-variability and data-inefficiency issues. Significance: As a consequence, it would enable one to improve the quality of automatic sleep staging models when the amount of data is relatively small.

25 October 2016 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
NPN. Palmius
N. Palmius
ATAthanasios Tsanas
Athanasios Tsanas
KSK. E. A. Saunders
K. E. A. Saunders
ABA. C. Bilderbeck
A. C. Bilderbeck
JGJ. R. Geddes
J. R. Geddes
Maarten De VosMaarten De Vos
Maarten De Vos
Objective: This paper aims to identify periods of depression using geolocation movements recorded from mobile phones in a prospective community study of individuals with bipolar disorder (BD). Methods: Anonymized geographic location recordings from 22 BD participants and 14 healthy controls (HC) were collected over 3 months. Participants reported their depressive symptomatology using a weekly questionnaire (QIDS-SR16). Recorded location data were preprocessed by detecting and removing imprecise data points and features were extracted to assess the level and regularity of geographic movements of the participant. A subset of features were selected using a wrapper feature selection method and presented to 1) a linear regression model and a quadratic generalized linear model with a logistic link function for questionnaire score estimation; and 2) a quadratic discriminant analysis classifier for depression detection in BD participants based on their questionnaire responses. Results: HC participants did not report depressive symptoms and their features showed similar distributions to nondepressed BD participants. Questionnaire score estimation using geolocation-derived features from BD participants demonstrated an optimal mean absolute error rate of 3.73, while depression detection demonstrated an optimal (median ± IQR) F 1 score of 0.857 ± 0.022 using five features (classification accuracy: 0.849 ± 0.016; sensitivity: 0.839 ± 0.014; specificity: 0.872 ± 0.047). Conclusion: These results demonstrate a strong link between geographic movements and depression in bipolar disorder. Significance: To our knowledge, this is the first community study of passively recorded objective markers of depression in bipolar disorder of this scale. The techniques could help individuals monitor their depression and enable healthcare providers to detect those in need of care or treatment.

21 September 2020 in IEEE Signal Processing Letters
Verified
Journal Article
Closed access
HPHuy Phan
Huy Phan
Ian McLoughlinIan McLoughlin
Ian McLoughlin
LPLam Pham
Lam Pham
OCOliver Chén
Oliver Chén
PKPhilipp Koch
Philipp Koch
AMAlfred Mertins
Alfred Mertins
Generative adversarial networks (GAN) have recently been shown to be efficient for speech enhancement. However, most, if not all, existing speech enhancement GANs (SEGAN) make use of a single generator to perform one-stage enhancement mapping. In this work, we propose to use multiple generators that are chained to perform multi-stage enhancement mapping, which gradually refines the noisy input signals in a stage-wise fashion. Furthermore, we study two scenarios: (1) the generators share their parameters and (2) the generators' parameters are independent. The former constrains the generators to learn a common mapping that is iteratively applied at all enhancement stages and results in a small model footprint. On the contrary, the latter allows the generators to flexibly learn different enhancement mappings at different stages of the network at the cost of an increased model size. We demonstrate that the proposed multi-stage enhancement approach outperforms the one-stage SEGAN baseline, where the independent generators lead to more favorable results than the tied generators. The source code is available at http://github.com/pquochuy/idsegan.

1 October 2017 in Early Human Development
Verified
Journal Article
Closed access
ADAnneleen Dereymaeker
Anneleen Dereymaeker
KPKirubin Pillay
Kirubin Pillay
JVJan Vervisch
Jan Vervisch
Maarten De VosMaarten De Vos
Maarten De Vos
SHSabine Van Huffel
Sabine Van Huffel
Gunnar NaulaersGunnar Naulaers
Gunnar Naulaers

27 March 2020 in medRxiv
Verified
Preprint
Open access
PDF file
LWLaure Wynants
Laure Wynants
BCBen Van Calster
Ben Van Calster
MBMarc Bonten
Marc Bonten
GCGary S Collins
Gary S Collins
TDThomas P. Debray
Thomas P. Debray
MSMaarten van Smeden
Maarten van Smeden
Objective: To review and critically appraise published and preprint reports of models that aim to predict either (i) presence of existing COVID-19 infection, (ii) future complications in individuals already diagnosed with COVID-19, or (iii) models to identify individuals at high risk for COVID-19 in the general population. Design: Rapid systematic review and critical appraisal of prediction models for diagnosis or prognosis of COVID-19 infection. Data sources: PubMed, EMBASE via Ovid, Arxiv, medRxiv and bioRxiv until 24 th March 2020. Study selection: Studies that developed or validated a multivariable COVID-19 related prediction model. Two authors independently screened titles, abstracts and full text. Data extraction: Data from included studies were extracted independently by at least two authors based on the CHARMS checklist, and risk of bias was assessed using PROBAST. Data were extracted on various domains including the participants, predictors, outcomes, data analysis, and prediction model performance. Results: 2696 titles were screened. Of these, 27 studies describing 31 prediction models were included for data extraction and critical appraisal. We identified three models to predict hospital admission from pneumonia and other events (as a proxy for covid-19 pneumonia) in the general population; 18 diagnostic models to detect COVID-19 infection in symptomatic individuals (13 of which were machine learning utilising computed tomography (CT) results); and ten prognostic models for predicting mortality risk, progression to a severe state, or length of hospital stay. Only one of these studies used data on COVID-19 cases outside of China. Most reported predictors of presence of COVID-19 in suspected patients included age, body temperature, and signs and symptoms. Most reported predictors of severe prognosis in infected patients included age, sex, features derived from CT, C-reactive protein, lactic dehydrogenase, and lymphocyte count. Estimated C-index estimates for the prediction models ranged from 0.73 to 0.81 in those for the general population (reported for all 3 general population models), from 0.81 to > 0.99 in those for diagnosis (reported for 13 of the 18 diagnostic models), and from 0.85 to 0.98 in those for prognosis (reported for 6 of the 10 prognostic models). All studies were rated at high risk of bias, mostly because of non-representative selection of control patients, exclusion of patients who had not experienced the event of interest by the end of the study, and poor statistical analysis, including high risk of model overfitting. Reporting quality varied substantially between studies. A description of the study population and intended use of the models was absent in almost all reports, and calibration of predictions was rarely assessed. Conclusion: COVID-19 related prediction models are quickly entering the academic literature, to support medical decision making at a time where this is urgently needed. Our review indicates proposed models are poorly reported and at high risk of bias. Thus, their reported performance is likely optimistic and using them to support medical decision making is not advised. We call for immediate sharing of the individual participant data from COVID-19 studies to support collaborative efforts in building more rigorously developed prediction models and validating (evaluating) existing models. The aforementioned predictors identified in multiple included studies could be considered as candidate predictors for new models. We also stress the need to follow methodological guidance when developing and validating prediction models, as unreliable predictions may cause more harm than benefit when used to guide clinical decisions. Finally, studies should adhere to the TRIPOD statement to facilitate validating, appraising, advocating and clinically using the reported models. Systematic review registration protocol: osf.io/ehc47/ , registration: osf.io/wy245 Summary boxes: What is already known on this topic: - The sharp recent increase in COVID-19 infections has put a strain on healthcare systems worldwide, necessitating efficient early detection, diagnosis of patients suspected of the infection and prognostication of COVID-19 confirmed cases. - Viral nucleic acid testing and chest CT are standard methods for diagnosing COVID-19, but are time-consuming. - Earlier reports suggest that the elderly, patients with comorbidity (COPD, cardiovascular disease, hypertension), and patients presenting with dyspnoea are vulnerable to more severe morbidity and mortality after COVID-19 infection. What this study adds: - We identified three models to predict hospital admission from pneumonia and other events (as a proxy for COVID-19 pneumonia) in the general population. - We identified 18 diagnostic models for COVID-19 detection in symptomatic patients. - 13 of these were machine learning models based on CT images. - We identified ten prognostic models for COVID-19 infected patients, of which six aimed to predict mortality risk in confirmed or suspected COVID-19 patients, two aimed to predict progression to a severe or critical state, and two aimed to predict a hospital stay of more than 10 days from admission. - Included studies were poorly reported compromising their subsequent appraisal, and recommendation for use in daily practice. All studies were appraised at high risk of bias, raising concern that the models may be flawed and perform poorly when applied in practice, such that their predictions may be unreliable.